169P_PR - Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)

Autor: Corral de la Fuente, E., Barquín García, A., Saavedra Serrano, C., Olmedo García, M.E., Martin Huertas, R., Serrano Domingo, J.J., Albarrán Artahona, V., Gómez Rueda, A.
Zdroj: In Annals of Oncology April 2019 30 Supplement 2:ii61-ii62
Databáze: ScienceDirect